Poster presentation on METAglut1™ our innovative IVD blood test at the meeting of SFNP 2022
February 2, 2022
Testimonial from Dr. Domitille Gras on our innovative IVD test METAglut™ during World Health Day 2022
April 7, 2022
February 17, 2022
[EVENTS] Company ; METAglut1™
We were excited to participate in the 48th meeting of the European Society for Pediatric Neurology (SENP) in Lausanne. This event offered a fantastic opportunity to connect with physicians from across Europe and share the results of our validation study for the METAglut1™ test.
This gathering brought together leading experts and practitioners in pediatric neurology to discuss the latest research and advancements in the field.
METAglut1™ is our innovative rapid IVD blood test, designed to aid the early diagnosis of GLUT1DS.
Glut1 Deficiency Syndrom (Glut1DS), also known as De Vivo Disease, is a rare neuro metabolic disorder that can significantly impact the lives of affected children.
We believe that our diagnostic tool represents a significant advancement in identifying the condition, which can have profound implications for affected individuals and their families.
We were particularly proud to have the results of our validation study for the METAglut1™ test presented by Josep Bonet, our Global Medical Manager at METAFORA Biosystems.
POSTER PRESENTATION:
“A blood test to improve the early diagnosis of Glut1 deficiency syndrome“
About the event organizer
The Société Européenne de Neurologie Pédiatrique (SENP+) is an international society made up of specialists in pediatric neurology, practicing in the south-western part of the European Community: France, Italy, Portugal, Belgium, Switzerland, Luxembourg and Spain.
Every year, the SENP+ organizes meetings reserved for members of the association and a few invited guests – mostly future candidate-members. At these meetings, participants discuss a series of predefined topics in collaboration with experts (members and non-members of the Society).
Since its creation, the SENP+ has played an active role in the development of pediatric neurology. All SENP+ members have been pioneers in the creation of pediatric neurology societies in their countries. The SENP+ is committed to providing warm, human-scale meetings that encourage exchanges between professionals and the development of caring collaborations for the benefit of young neuropediatricians in training.
Sharing our validation study results at the 48th meeting of the European Society for Pediatric Neurology (SENP) has invigorated our commitment to advancing research and innovation in pediatric health. We are dedicated to collaborating with experts and stakeholders to improve patient outcomes and have the test as fast as possible covered and available.
